Net profit of Natco Pharma declined 23.46% to Rs 518.40 crore in the quarter ended September 2025 as against Rs 677.30 crore during the previous quarter ended September 2024. Sales declined 0.59% to Rs 1363.00 crore in the quarter ended September 2025 as against Rs 1371.10 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 1363.00 | 1371.10 | -1 |
| OPM % | 42.49 | 58.66 | - |
| PBDT | 666.10 | 864.00 | -23 |
| PBT | 613.70 | 818.20 | -25 |
| NP | 518.40 | 677.30 | -23 |